Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel Monotherapy in Untreated Patients With Partial-Onset Seizures
jRCT2080223588Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2017
- Modality
- Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of perampanel in epilepsy, sponsored by Eisai Co., Ltd. Started Jul 2017; status: completed.
02
Drugs
perampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on jRCT2080223588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223588.